In an open investigation on 50 patients with various dermatological lesions 17 (81%) out of 21 psoriatics and 28 out of 29 other patients improved considerably or were clinically cured after three weeks' treatment with an ointment containing 0·05% betamethasone dipropionate and 3·0% chinoform. Among the patients chosen for the study 34 had previously tried topical corticosteroids without success. Of these 31 improved markedly during the steroid trial.
Get full access to this article
View all access options for this article.
References
1.
FredrikssonTGipL (1974) A new synthetic steroid: Betamethasone 17,21-dipropionate. Clinical Trials Journal11 (1), 14
2.
RiethH (1962) The Antimycotics: Handbook of Skin and Sexual Diseases inJ Jadassonn5 (1B), 1212. Berlin/Göttingen/Heidelberg (Springer)
3.
RossCM (1974) Diprosone ointment in psoriasis. South African Medical Journal (Oct 5, 1974), 2030
4.
ScherrerH (1971) The antimicrobial activity of broad spectrum antimicrobials, with particular attention to salicylic acid and chinoform. Mykosen14 (7), 323
5.
SzodorayL (1974) The clinical evaluation of a new topical steroid: Betamethasone 17,21-dipropionate. Journal of International Medical Research2, 428
6.
TølløfsrudA (1974) Psoriasis and other steroid responsive dermatoses. A double-blind comparison of betamethasone 17,21-dipropionate (Diprosone) with fluocinolone acetonide. Clinical Trials Journal11 (4), 143
